S01LA04 Ranibizumab
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 5 drugs in this drug class.
- 5 prescription (Rx)
Active ingredient: Ranibizumab – all drugs with this active ingredient, also in combination.
Place in the ATC system
- S Sensory organ drugs 335 drugs
- S01 Ophthalmologicals 324 drugs
- S01L Ocular vascular disorder agents 18 drugs
- S01LA Antineovascularisation agents 18 drugs
- S01LA04 Ranibizumab 5 drugs
- S01LA Antineovascularisation agents 18 drugs
- S01L Ocular vascular disorder agents 18 drugs
- S01 Ophthalmologicals 324 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Lucentis | prescription (Rx) |
| Melvizo PM | prescription (Rx) |
| Ranopto | prescription (Rx) |
| Ranvu | prescription (Rx) |
| Susvimo PM | prescription (Rx) |
Other classes of the same level
- S01LA01 Verteporfin 1 drug
- S01LA03 Pegaptanib 1 drug
- S01LA05 Aflibercept 9 drugs
- S01LA06 Brolucizumab 1 drug
- S01LA09 Faricimab 1 drug
Other names of the drug class
- Czech: S01LA04 Ranibizumab
- English (United Kingdom): S01LA04 ranibizumab
- German: S01LA04 Ranibizumab
- German (Austria): S01LA04 Ranibizumab
- Italian: S01LA04 RANIBIZUMAB
- Turkish: S01LA04 ranibizumab
- Portuguese (Brazil): S01LA04 Ranibizumab
- German (Switzerland): S01LA04 Ranibizumab
- French (Switzerland): S01LA04 Ranibizumab
- Italian (Switzerland): S01LA04 Ranibizumab
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class S01LA04
Ask your doctor or pharmacist for advice.